Literature DB >> 25192554

Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease.

Valentin Prieto-Centurion1, Andrew J Rolle, David H Au, Shannon S Carson, Ashley G Henderson, Todd A Lee, Peter K Lindenauer, Mary A McBurnie, Richard A Mularski, Edward T Naureckas, William M Vollmer, Binoy J Joese, Jerry A Krishnan.   

Abstract

RATIONALE: Clinical trials in chronic obstructive pulmonary disease (COPD) usually require evidence of airflow obstruction and clinical risk factors. International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes or patient-reported physician diagnoses are often used for epidemiologic studies and performance improvement programs.
OBJECTIVES: To evaluate agreement between these case definitions for COPD and to assess the comparability of study populations identified as having COPD not using the clinical trial reference standard.
METHODS: We recruited patients from the COPD Outcomes-based Network for Clinical Effectiveness and Research Translation multicenter clinical registry in a cross-sectional study. Demographics, clinical, and post-bronchodilator spirometry data were collected at an in-person study visit. The kappa statistic (κ) was used to evaluate agreement. A multivariable logistic regression model was used to identify patient characteristics associated with meeting the trial reference standard.
MEASUREMENTS AND MAIN RESULTS: A total of 998 (82.8%) of 1,206 study participants met at least one case definition for COPD (of the 998: 91% using ICD-9 codes, 73% using patient-reported physician diagnosis, 56% using trial reference standard); agreement between case definitions was poor (κ = 0.20-0.26). Lack of airflow obstruction was the principal (89%) reason patients identified as having COPD did not meet the trial reference standard. Patients who were black (vs. white), obese (vs. normal weight), or had depression (vs. not) were less likely to meet the trial reference standard (odds ratio [95% CI], 0.37 [0.26-0.53], 0.51 [0.34-0.75], 0.53 [0.40-0.71], respectively).
CONCLUSIONS: Findings highlight concerns about the applicability of findings in clinical trials to patients meeting other case definitions for COPD.

Entities:  

Keywords:  COPD; ICD-9-CM; case definitions; comparative effectiveness; spirometry

Mesh:

Year:  2014        PMID: 25192554      PMCID: PMC4299587          DOI: 10.1164/rccm.201406-1166OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

Authors:  D M Mannino; R C Gagnon; T L Petty; E Lydick
Journal:  Arch Intern Med       Date:  2000-06-12

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

Authors:  Fernando Holguin; Erik Folch; Stephen C Redd; David M Mannino
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

4.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

5.  External validity of randomized controlled trials in COPD.

Authors:  Justin Travers; Suzanne Marsh; Brent Caldwell; Mathew Williams; Sarah Aldington; Mark Weatherall; Philippa Shirtcliffe; Richard Beasley
Journal:  Respir Med       Date:  2006-11-17       Impact factor: 3.415

6.  Diagnostic labeling of COPD in five Latin American cities.

Authors:  Carlos Tálamo; Maria Montes de Oca; Ron Halbert; Rogelio Perez-Padilla; José Roberto B Jardim; Adriana Muiño; Maria Victorina Lopez; Gonzalo Valdivia; Julio Pertuzé; Dolores Moreno; Ana Maria B Menezes
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

7.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

8.  Validation and comparison of reference equations for the 6-min walk distance test.

Authors:  C G Cote; C Casanova; J M Marín; M V Lopez; V Pinto-Plata; M M de Oca; L J Dordelly; H Nekach; B R Celli
Journal:  Eur Respir J       Date:  2007-11-07       Impact factor: 16.671

9.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

10.  Airway obstruction is common but unsuspected in patients admitted to a general medicine service.

Authors:  David Zaas; Robert Wise; Charles Wiener
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

View more
  24 in total

1.  Trait Insights Gained by Comparing Genome-Wide Association Study Results using Different Chronic Obstructive Pulmonary Disease Definitions.

Authors:  Jaehyun Joo; Brian D Hobbs; Michael H Cho; Blanca E Himes
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2020-05-30

2.  Poor Metered-Dose Inhaler Technique Is Associated with Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease.

Authors:  Matthew F Griffith; Laura C Feemster; Lucas M Donovan; Laura J Spece; Jerry A Krishnan; Peter K Lindenauer; Mary A McBurnie; Richard A Mularski; David H Au
Journal:  Ann Am Thorac Soc       Date:  2019-06

3.  Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease.

Authors:  Lucas M Donovan; Peter J Rise; Shannon S Carson; Laura C Feemster; Matthew F Griffith; Vishesh K Kapur; Jerry A Krishnan; Peter K Lindenauer; Richard A Mularski; Edward T Naureckas; Brian N Palen; Elizabeth C Parsons; Laura J Spece; Michael V Vitiello; David H Au
Journal:  Ann Am Thorac Soc       Date:  2017-12

4.  Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.

Authors:  Anne C Melzer; Bijan J Ghassemieh; Suzanne E Gillespie; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; David H Au
Journal:  Respir Med       Date:  2016-12-20       Impact factor: 3.415

5.  Accuracy of electronic health record data for the diagnosis of chronic obstructive pulmonary disease in persons living with HIV and uninfected persons.

Authors:  Kristina Crothers; Carla V Rodriguez; Robin M Nance; Kathleen Akgun; Shahida Shahrir; Joon Kim; Guy W Soo Hoo; Amir Sharafkhaneh; Heidi M Crane; Amy C Justice
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-06-20       Impact factor: 2.890

6.  An Official American Thoracic Society Workshop Report. A Framework for Addressing Multimorbidity in Clinical Practice Guidelines for Pulmonary Disease, Critical Illness, and Sleep Disorders.

Authors:  Kevin C Wilson; Michael K Gould; Jerry A Krishnan; Cynthia M Boyd; Jan L Brozek; Colin R Cooke; Ivor S Douglas; Richard A Goodman; Min J Joo; Suzanne Lareau; Richard A Mularski; Minal R Patel; Richard M Rosenfeld; Hasan Shanawani; Christopher Slatore; Marianna Sockrider; Beth Sufian; Carey C Thomson; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2016-03

7.  Recruiting Patients After Hospital Discharge for Acute Exacerbation of COPD: Challenges and Lessons Learned.

Authors:  Gary T Ferguson; Bonnie Beck; Emmanuelle Clerisme-Beaty; Dacheng Liu; Byron M Thomashow; Robert A Wise; Richard ZuWallack; Barry J Make
Journal:  Chronic Obstr Pulm Dis       Date:  2017-08-10

8.  Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods.

Authors:  Rachel L Richesson; Jimeng Sun; Jyotishman Pathak; Abel N Kho; Joshua C Denny
Journal:  Artif Intell Med       Date:  2016-06-25       Impact factor: 5.326

9.  Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.

Authors:  Anne C Melzer; Laura C Feemster; Kristina Crothers; Shannon S Carson; Suzanne E Gillespie; Ashley G Henderson; Jerry A Krishnan; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; A Simon Pickard; David H Au
Journal:  Ann Am Thorac Soc       Date:  2016-09

10.  Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Russell G Buhr; Nicholas J Jackson; Steven M Dubinett; Gerald F Kominski; Carol M Mangione; Michael K Ong
Journal:  J Hosp Med       Date:  2020-02-11       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.